GSA CAPITAL PARTNERS LLP - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$785
-99.8%
3,240
-32.2%
0.08%
+52.9%
Q4 2021$405,000
-44.6%
4,780
-47.8%
0.05%
-31.1%
Q3 2021$731,000
+50.1%
9,156
+83.0%
0.07%
+34.5%
Q2 2021$487,000
+31.3%
5,003
+50.1%
0.06%
-9.8%
Q4 2020$371,000
-66.7%
3,334
-72.8%
0.06%
-53.1%
Q4 2019$1,115,000
+251.7%
12,241
+232.9%
0.13%
+202.3%
Q3 2019$317,000
-33.4%
3,677
+116.0%
0.04%
+79.2%
Q2 2018$476,0001,7020.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PACIFIC VIEW ASSET MANAGEMENT, LLC 25,070$2,825,0003.32%
HealthCor Management, L.P. 688,890$77,652,0002.43%
Avoro Capital Advisors LLC 225,000$25,362,0001.52%
EMORY UNIVERSITY 17,038$1,921,0001.51%
Rock Springs Capital Management LP 241,000$27,166,0001.28%
Baker Brothers Advisors 1,169,278$131,801,0001.08%
Caption Management, LLC 100,800$11,362,0000.91%
SHIKIAR ASSET MANAGEMENT INC 14,341$1,617,0000.84%
Pier Capital, LLC 37,654$4,244,0000.84%
Atika Capital Management LLC 20,000$2,254,0000.66%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders